[1]CurrentPatentAssignee:DINGTAOCOUNTYYOUBANGCHEMICALINDUSTRY-CN103965192,2016,BLocationinpatent:Paragraph0045;0047
[2]CurrentPatentAssignee:KYMERATHERAPEUTICSINC-WO2021/158634,2021,A1Locationinpatent:Paragraph00588
1227268-77-0
1260797-60-1
138642-96-3
182181-19-7
29096-59-1
6200-60-8
138775-48-1 | Fmoc-D-Tyr(Bzl)-OH | AA0019H1 | MFCD00235837
13906-08-6 | 3-Ethyl-2-thioxo-1,2,3,4-tetrahydroquinazolin-4-one | AA001A11 | MFCD00126093
139264-15-6 | 2-Oxazolidinone, 4-[[3-(2-aminoethyl)-1H-indol-5-yl]methyl]-, (4S)- | AA001AIH | MFCD09833109
13940-38-0 | Periodic acid (H5IO6), sodium salt (1:3) | AA001AV9 | MFCD00036146
1396779-99-9 | Ethyl 6-bromo-3-methyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylate | AA001BEM | MFCD27987706
140-38-5 | 4-Chlorophenylurea | AA001BUU | MFCD00014788
140373-77-9 | tert-Butyl 4-amino-2-fluorobenzoate | AA001C7B | MFCD06658385
140692-40-6 | 2-Oxo-6-[3-(trifluoromethyl)phenyl]-1,2-dihydro-3-pyridinecarbonitrile | AA001CM7 | MFCD00215071
140860-51-1 | 2-bromo-4-methoxybenzonitrile | AA001CUT | MFCD09056764
145692-57-5 | 6-Methoxy-1h-indole-3-carbonitrile | AA001D87 | MFCD07778405